NVG

NYSE Nuveen AMT-Free Municipal Credit Income Fund
Oct 16, 2026 · 10:50 PM ET EOD Market Closed

$10.89 ↑ +0.00 (+0.00%) Trading Up from the previous close of $10.89, $0.04 below the day’s high of $10.93

YTD change
-13.98%
vs 20-day SMA
+0.96%
vs 200-day SMA
-12.26%

Price ranges

Previous day
$10.66 $10.86
open $10.66 close $10.83
+$0.17 (+1.59%)
Today
$10.75 $10.93
open $10.83 now $10.89
+$0.06 (+0.55%)
Past week
$10.57 $10.89
from $10.57 now $10.89
+$0.32 (+3.03%)
Past month
$10.29 $11.57
from $11.56 now $10.89
-$0.67 (-5.80%)
This year
$10.29 $13.59
from $12.66 now $10.89
-$1.77 (-13.98%)

Price & Performance

-1.63 (-13.02%) / 6M

$10.23$11.17$12.10$13.04Apr 16Jul 17Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 40.4% away from all-time highs of $18.27
  • NVG is down 14% since the beginning of the year
  • NVG is down 12% over the past 12 months
  • NVG is down 6% over the past 1 month

NVG reads neutral: price sits above one of the two key moving averages, the 12-month move is -12.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-89.7083
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Finance and Insurance
Sub Sector Securities, Commodity Contracts, and Other Financial Investments and Related Activities
Market cap $324.6M

Competitor comparison

TickerCompany PriceChange
JPM JPMorgan Chase & Co. $339.72 +1.25%
MS Morgan Stanley $180.57 -0.84%
GS Goldman Sachs Group, Inc. $881.26 -1.12%
C Citigroup Inc. $124.26 +0.85%
BLK BlackRock, Inc. $1,134.38 +1.21%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.